Home » Topics » Regulatory

Regulatory
RSS

FDA approves Bavencio for metastatic Merkel cell carcinoma

March 24, 2017

FDA approves Keytruda for classical Hodgkin's lymphoma

March 15, 2017

FDA approves Kisqali for HR+/HER2- breast cancer

March 14, 2017

First European approval of new breast cancer indication for Decapeptyl

March 13, 2017

FDA approves Xermelo for carcinoid syndrome diarrhea

March 1, 2017

EC approves Revlimid in new indication

Feb. 27, 2017

FDA approves Revlimid as maintenance therapy in multiple myeloma after autologous HSCT

Feb. 23, 2017

Truxima becomes the first biosimilar MAb in oncology to be granted E.U. marketing authorization

Feb. 23, 2017

European Commission approves Olumiant for rheumatoid arthritis

Feb. 14, 2017

Marathon Pharmaceuticals' Emflaza approved by FDA for DMD

Feb. 10, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...